GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
101 hedge funds and large institutions have $754M invested in Genomic Health, Inc. in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
53% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 30
78% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $9.61M
Holders
101
Holding in Top 10
1
Calls
$2.1M
Puts
$9.61M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$19.6M | |
| 3 | +$8.09M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.66M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$4.86M |
Top Sellers
| 1 | -$27M | |
| 2 | -$3.54M | |
| 3 | -$3.19M | |
| 4 |
Goldman Sachs
New York
|
-$2.75M |
| 5 |
Morgan Stanley
New York
|
-$2.2M |